Case# 2. A 5-year old boy, transplanted in 1992 for Fanconi's anemia from his HLA-identical
brother, developed progressive extensive cGvHD, barely controlled by standard …

Abstract Extracorporeal photochemotherapy (ECP; photopheresis), an immunomodulatory
therapy developed for cutaneous T‐cell lymphoma, has shown promise in treating chronic …

Background: The results of a recent study suggested that ultraviolet A1 radiation (UVA1R;
340-400 nm) phototherapy for atopic dermatitis works through induction of apoptosis in skin …

Steroids remain the initial therapy for acute graft-vs.-host disease (AGVHD). Strategies to
improve response and minimize steroid exposure are needed. We report results of a …

Abstract Summary Long‐wavelength ultraviolet A (340–400 nm; UVA1) therapy is currently
available in only a few dermatology departments. Equipment capable of delivering this …

Extracorporeal exposure of peripheral blood mononuclear cells to the photosensitizing
agent 8-methoxypsoralen and UV-A radiation has been shown to be effective in the …

Photopheresis (extracorporeal photochemotherapy, ECP) is a new type of
photochemotherapy used for the treatment of oncological and autoimmune diseases …

Cutaneous involvement in graft versus host disease (GVHD) after allogeneic hematopoietic
cell transplant can be separated into acute GVHD (aGVHD), lichenoid chronic GVHD …

The ultraviolet radiation (UVR) spectrum ranges from 10 nm at its highest energy to 400 nm
at the lowest energy and is subdivided based on the biological effects of a given …

Chronic graft-versus-host disease (GVHD) is a major limitation of successful allogeneic
hematopoietic stem cell transplantation (HSCT). Extracorporeal photochemotherapy (ECP) …